Hyperhomocysteinemia: detection, risk assessment, and treatment

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Metabolic Disorders

Background:

• Homocysteine, a metabolite of methionine, plays a role in normal metabolic processes.
• Elevated homocysteine levels (hyperhomocysteinemia) are recognized as an independent risk factor for vascular disease.
• Common causes of hyperhomocysteinemia include folate deficiency, genetic factors, and chronic kidney disease.

Purpose of the Study:

• To investigate the role of homocysteine in vascular disease pathogenesis.
• To explore the mechanisms by which hyperhomocysteinemia contributes to vascular damage.
• To evaluate the potential of folic acid in managing hyperhomocysteinemia and mitigating vascular risk.

Main Methods:

• Review of current literature on homocysteine metabolism and vascular disease.
• Analysis of proposed pathogenetic models involving endothelial and smooth muscle cells.
• Examination of the impact on thrombolysis processes.

Main Results:

• Hyperhomocysteinemia is linked to direct vascular toxicity.
• Mechanisms include damage to endothelial and vascular smooth muscle cells.
• Impaired thrombolysis is another contributing factor to vascular risk.

Conclusions:

• Folic acid effectively reduces elevated homocysteine levels.
• Lowering homocysteine through folic acid supplementation presents a viable strategy for vascular risk factor modification.